Vincenzo Dinallo
Overview
Explore the profile of Vincenzo Dinallo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinallo V, Di Fusco D, Di Grazia A, Laudisi F, Troncone E, Di Maggio G, et al.
J Crohns Colitis
. 2021 Jul;
16(1):122-132.
PMID: 34232309
Background And Aims: The inflammatory bowel disease [IBD]-associated immune response is marked by excessive production of a variety of inflammatory cytokines, which are supposed to sustain and amplify the pathological...
2.
Di Grazia A, Marafini I, Pedini G, Di Fusco D, Laudisi F, Dinallo V, et al.
Cell Mol Gastroenterol Hepatol
. 2020 Oct;
11(2):639-658.
PMID: 33091622
Background & Aims: The fragile X mental retardation protein (FMRP) affects multiple steps of the mRNA metabolism during brain development and in different neoplastic processes. However, the contribution of FMRP...
3.
Franze E, Dinallo V, Laudisi F, Di Grazia A, Di Fusco D, Colantoni A, et al.
J Crohns Colitis
. 2020 Apr;
14(10):1436-1445.
PMID: 32271873
Background And Aim: The mechanisms underlying the formation of intestinal fibrostrictures [FS] in Crohn's disease [CD] are not fully understood, but activation of fibroblasts and excessive collagen deposition are supposed...
4.
Di Fusco D, Stolfi C, Di Grazia A, Dinallo V, Laudisi F, Marafini I, et al.
Clin Sci (Lond)
. 2020 Apr;
134(7):907-920.
PMID: 32236445
Background: Increased keratinocyte proliferation occurs in the skin of psoriatic patients and is supposed to play a role in the pathogenesis of this disorder. Compounds interfering with keratinocyte proliferation could...
5.
Franze E, Monteleone I, Laudisi F, Rizzo A, Dinallo V, Di Fusco D, et al.
J Crohns Colitis
. 2019 Sep;
14(3):406-417.
PMID: 31504344
Background And Aims: Although the mechanisms underlying the formation of intestinal fibrostrictures in Crohn's disease [CD] are not fully understood, activation of fibroblasts and excessive collagen deposition are supposed to...
6.
Marafini I, Sedda S, Dinallo V, Monteleone G
Expert Opin Biol Ther
. 2019 Aug;
19(11):1207-1217.
PMID: 31373244
: Although the etiology of inflammatory bowel diseases (IBD) remains unknown, accumulating evidence suggests that the intestinal tissue damage in these disorders is due to a dynamic interplay between immune...
7.
Laudisi F, Cherubini F, Di Grazia A, Dinallo V, Di Fusco D, Franze E, et al.
Mol Oncol
. 2019 Jul;
13(10):2142-2159.
PMID: 31361391
Persistent activation of Signal Transducer and Activator of Transcription (STAT)3 occurs in a high percentage of tumors, including colorectal cancer (CRC), thereby contributing to malignant cell proliferation and survival. Although...
8.
Laudisi F, Di Grazia A, De Simone V, Cherubini F, Colantoni A, Ortenzi A, et al.
Cancer Lett
. 2019 Jul;
462:1-11.
PMID: 31351087
Colorectal cancer (CRC) remains one of the leading causes of mortality worldwide. Drug repositioning is a promising approach for new cancer therapies, as it provides the opportunity to rapidly advance...
9.
Marafini I, Di Fusco D, Dinallo V, Franze E, Stolfi C, Sica G, et al.
Front Pharmacol
. 2019 Apr;
10:380.
PMID: 31031628
Defects in counterregulatory mechanisms contribute to amplify the detrimental inflammatory response leading to the pathologic process occurring in the gut of patients with Crohn's disease (CD) and ulcerative colitis (UC),...
10.
Di Fusco D, Dinallo V, Marafini I, Figliuzzi M, Romano B, Monteleone G
Front Pharmacol
. 2019 Apr;
10:305.
PMID: 30983999
Several molecular technologies aimed at regulating gene expression that have been recently developed as a strategy to combat inflammatory and neoplastic diseases. Among these, antisense technology is a specific, rapid,...